An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity.
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004299:Dopamine beta-Hydroxylase / Q000097:blood*; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy / Q000201:enzymology*
D014150:Antipsychotic Agents; D004299:Dopamine beta-Hydroxylase